This protocol covers the management of gonococcal conjunctivitis in adult patients aged 18 years or older who have no documented allergy to cephalosporin antibiotics. The absence of cephalosporin allergy is the key eligibility criterion that shapes the treatment options available.
The patient is an adult (18 years of age or older) presenting with gonococcal conjunctivitis caused by Gonococcus. There is no cephalosporin allergy, which determines the range of antibiotic options applicable in this case.
Management in this population involves a combination of antibiotic therapies — including both an injectable and an oral agent — along with a local supportive eye care measure. The full protocol specifies the agents, their roles, sequencing, and alternatives.